Montelukast in Chronic Asthma

Organon

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00802789

2008_031 (Other Identifier)

MK-0476-421

0476-421

Details and patient eligibility

About

Treatment of patients insufficiently treated with ICS or ICS + LABA.

Enrollment: 2,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients Insufficiently Treated With ICS Or ICS + LABA.

Trial design

2,000 participants in 1 patient group

1

Description:

Mild to moderate adult asthmatics (≥18years of age) insufficiently treated with ICS or ICS + LABA.